日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication

基于miR-28的联合疗法通过重塑DNA复制来抑制侵袭性B细胞淋巴瘤的生长

Teresa Fuertes ,Emigdio Álvarez-Corrales ,Carmen Gómez-Escolar ,Patricia Ubieto-Capella ,Álvaro Serrano-Navarro ,Antonio de Molina ,Juan Méndez ,Almudena R Ramiro # ,Virginia G de Yébenes #

Genetic alterations of the SUMO isopeptidase SENP6 drive lymphomagenesis and genetic instability in diffuse large B-cell lymphoma

SUMO异肽酶SENP6的基因改变驱动弥漫性大B细胞淋巴瘤的淋巴瘤发生和遗传不稳定性

Markus Schick ,Le Zhang ,Sabine Maurer ,Hans Carlo Maurer ,Konstandina Isaakaidis ,Lara Schneider ,Upayan Patra ,Kathrin Schunck ,Elena Rohleder ,Julia Hofstetter ,Apoorva Baluapuri ,Anna Katharina Scherger ,Julia Slotta-Huspenina ,Franziska Hettler ,Julia Weber ,Thomas Engleitner ,Roman Maresch ,Jolanta Slawska ,Richard Lewis ,Rouzanna Istvanffy ,Stefan Habringer ,Katja Steiger ,Armin Baiker ,Robert A J Oostendorp ,Cornelius Miething ,Hans-Peter Lenhof ,Florian Bassermann ,Björn Chapuy ,Matthias Wirth ,Elmar Wolf ,Roland Rad ,Stefan Müller ,Ulrich Keller

A kinase-independent function for AURORA-A in replisome assembly during DNA replication initiation

AURORA-A 在 DNA 复制起始过程中的复制体组装中发挥激酶非依赖性功能

Estrella Guarino Almeida, Xavier Renaudin, Ashok R Venkitaraman

Human CTC1 promotes TopBP1 stability and CHK1 phosphorylation in response to telomere dysfunction and global replication stress

人类 CTC1 促进 TopBP1 稳定性和 CHK1 磷酸化,以应对端粒功能障碍和整体复制压力

Stephanie M Ackerson, Caroline I Gable, Jason A Stewart

ATAD5 promotes replication restart by regulating RAD51 and PCNA in response to replication stress

ATAD5通过调控RAD51和PCNA来促进复制重启,以应对复制压力。

Su Hyung Park ,Nalae Kang ,Eunho Song ,Minwoo Wie ,Eun A Lee ,Sunyoung Hwang ,Deokjae Lee ,Jae Sun Ra ,In Bae Park ,Jieun Park ,Sukhyun Kang ,Jun Hong Park ,Sungchul Hohng ,Kyoo-Young Lee ,Kyungjae Myung

PALB2 connects BRCA1 and BRCA2 in the G2/M checkpoint response

PALB2 在 G2/M 检查点反应中连接 BRCA1 和 BRCA2

Srilatha Simhadri, Gabriele Vincelli, Yanying Huo, Sarah Misenko, Tzeh Keong Foo, Johanna Ahlskog, Claus S Sørensen, Gregory G Oakley, Shridar Ganesan, Samuel F Bunting, Bing Xia

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation

通过突变 p53 再激活对 BRCA1 和 TP53 突变乳腺癌进行治疗靶向治疗

Bing Na, Xin Yu, Tracy Withers, John Gilleran, Ming Yao, Tzeh Keong Foo, Chunxia Chen, Dirk Moore, Yong Lin, S David Kimball, Bing Xia, Shridar Ganesan #, Darren R Carpizo #

Loss of p53 suppresses replication-stress-induced DNA breakage in G1/S checkpoint deficient cells

p53 的缺失可抑制 G1/S 检查点缺陷细胞中复制应激诱导的 DNA 断裂

Bente Benedict #, Tanja van Harn #, Marleen Dekker, Simone Hermsen, Asli Kucukosmanoglu, Wietske Pieters, Elly Delzenne-Goette, Josephine C Dorsman, Eva Petermann, Floris Foijer, Hein Te Riele

A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cells

用于测量活细胞中药物-靶标结合的高含量、高通量细胞热稳定性检测

Andrew J Massey

Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation

去泛素化酶 USP3 控制 CHK1 染色质的结合和活化

Yu-Che Cheng, Sheau-Yann Shieh